Clinical Trials in Houston

Showing 12041-12060 of 17,885 trials

Norovirus Bivalent-Vaccine Efficacy Study

NCT01609257

The purpose of this study is to determine whether the norovirus vaccine is effective in preventing acute gastroenteritis due to the experimental human Norovirus GII.4 challenge dose. The purpose is also to evaluate the safety of the vaccine and the immunogenicity of the vaccine.

Prevention From Norovirus Infection

Takeda132 participantsStarted Jul 2012

Atlanta, Georgia, United States • Baltimore, Maryland, United States • Rochester, New York, United States +2 more locations

COMPLETEDPhase 3< 1 mile

Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer

NCT00678392

The study is designed to demonstrate that axitinib (AG-013736) is superior to sorafenib in delaying tumor progression in patients with metastatic renal cell cancer after failure of one first line regimen.

Kidney Neoplasms

Pfizer723 participantsStarted Sep 2008

Burbank, California, United States • Burbank, California, United States • Downey, California, United States +291 more locations

Norovirus Bivalent-Vaccine Efficacy Study

Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer

Find Trials by Condition in Houston

A Study in Adult Subjects With Select Advanced Solid Tumors

JKB-121 for the Treatment of Nonalcoholic Steatohepatitis

Post-Traumatic Stress Symptoms (PTSS) in Transplant Recipients

Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR2)

Trial Comparing Iron Supplementation Versus Routine Iron Intake in Very Low Birth Weight Infants

Digital Tools for Coping With Chronic Pain

Study of SC-003 Alone and in Combination With ABBV-181 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer

A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors

A Phase 2A Study of ALXN1007 in Participants With Newly Diagnosed Acute Lower Gastrointestinal Graft-Versus-Host Disease

Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients

Study to Evaluate the Safety and Efficacy of the Cytrellis Micro-Coring Device for the Treatment of Moderate to Severe Facial Wrinkles

Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO

A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects

A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer

Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer

Dacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung

A Study of Atezolizumab in Participants With Programmed Death-Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [FIR]

Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma